CLNN
Price
$3.90
Change
-$0.05 (-1.27%)
Updated
Jul 3 closing price
Capitalization
35.03M
KZIA
Price
$6.58
Change
-$0.00 (-0.00%)
Updated
Jul 3 closing price
Capitalization
9.18M
Interact to see
Advertisement

CLNN vs KZIA

Header iconCLNN vs KZIA Comparison
Open Charts CLNN vs KZIABanner chart's image
Clene
Price$3.90
Change-$0.05 (-1.27%)
Volume$32.79K
Capitalization35.03M
Kazia Therapeutics
Price$6.58
Change-$0.00 (-0.00%)
Volume$412
Capitalization9.18M
CLNN vs KZIA Comparison Chart in %
Loading...
CLNN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KZIA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLNN vs. KZIA commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLNN is a Hold and KZIA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (CLNN: $3.90 vs. KZIA: $6.58)
Brand notoriety: CLNN and KZIA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLNN: 34% vs. KZIA: 0%
Market capitalization -- CLNN: $35.03M vs. KZIA: $9.18M
CLNN [@Biotechnology] is valued at $35.03M. KZIA’s [@Biotechnology] market capitalization is $9.18M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLNN’s FA Score shows that 0 FA rating(s) are green whileKZIA’s FA Score has 0 green FA rating(s).

  • CLNN’s FA Score: 0 green, 5 red.
  • KZIA’s FA Score: 0 green, 5 red.
According to our system of comparison, KZIA is a better buy in the long-term than CLNN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLNN’s TA Score shows that 5 TA indicator(s) are bullish while KZIA’s TA Score has 5 bullish TA indicator(s).

  • CLNN’s TA Score: 5 bullish, 5 bearish.
  • KZIA’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both CLNN and KZIA are a good buy in the short-term.

Price Growth

CLNN (@Biotechnology) experienced а -0.51% price change this week, while KZIA (@Biotechnology) price change was +0.77% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

CLNN is expected to report earnings on May 07, 2025.

KZIA is expected to report earnings on Jun 10, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CLNN($35M) has a higher market cap than KZIA($9.18M). KZIA (-25.650) and CLNN (-26.554) have similar YTD gains . CLNN has higher annual earnings (EBITDA): -24.01M vs. KZIA (-26.77M). KZIA has higher revenues than CLNN: KZIA (2.31M) vs CLNN (350K).
CLNNKZIACLNN / KZIA
Capitalization35M9.18M381%
EBITDA-24.01M-26.77M90%
Gain YTD-26.554-25.650104%
P/E RatioN/AN/A-
Revenue350K2.31M15%
Total Cash9.83MN/A-
Total Debt20.9MN/A-
FUNDAMENTALS RATINGS
CLNN vs KZIA: Fundamental Ratings
CLNN
KZIA
OUTLOOK RATING
1..100
6298
VALUATION
overvalued / fair valued / undervalued
1..100
86
Overvalued
48
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
5740
P/E GROWTH RATING
1..100
97100
SEASONALITY SCORE
1..100
22n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

KZIA's Valuation (48) in the Biotechnology industry is somewhat better than the same rating for CLNN (86) in the null industry. This means that KZIA’s stock grew somewhat faster than CLNN’s over the last 12 months.

KZIA's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as CLNN (100) in the null industry. This means that KZIA’s stock grew similarly to CLNN’s over the last 12 months.

KZIA's SMR Rating (100) in the Biotechnology industry is in the same range as CLNN (100) in the null industry. This means that KZIA’s stock grew similarly to CLNN’s over the last 12 months.

KZIA's Price Growth Rating (40) in the Biotechnology industry is in the same range as CLNN (57) in the null industry. This means that KZIA’s stock grew similarly to CLNN’s over the last 12 months.

CLNN's P/E Growth Rating (97) in the null industry is in the same range as KZIA (100) in the Biotechnology industry. This means that CLNN’s stock grew similarly to KZIA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CLNNKZIA
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
78%
Bearish Trend 3 days ago
89%
MACD
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
87%
Bullish Trend 3 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
86%
Bullish Trend 3 days ago
78%
Advances
ODDS (%)
Bullish Trend 20 days ago
81%
Bullish Trend 24 days ago
81%
Declines
ODDS (%)
Bearish Trend 9 days ago
89%
Bearish Trend 9 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
87%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 3 days ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
CLNN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KZIA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WOOF3.080.13
+4.41%
Petco Health and Wellness Company
CLRB4.73N/A
N/A
Cellectar Biosciences Inc
SPCE2.81-0.02
-0.71%
Virgin Galactic Holdings
MAS66.38-0.90
-1.34%
Masco Corp
EVO4.20-0.14
-3.23%
Evotec SE

CLNN and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLNN has been loosely correlated with LYRA. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if CLNN jumps, then LYRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLNN
1D Price
Change %
CLNN100%
N/A
LYRA - CLNN
38%
Loosely correlated
-3.33%
VERA - CLNN
34%
Loosely correlated
N/A
KZIA - CLNN
33%
Poorly correlated
N/A
BPMC - CLNN
31%
Poorly correlated
N/A
GOSS - CLNN
30%
Poorly correlated
+2.48%
More

KZIA and

Correlation & Price change

A.I.dvisor tells us that KZIA and CLNN have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KZIA and CLNN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KZIA
1D Price
Change %
KZIA100%
N/A
CLNN - KZIA
33%
Poorly correlated
N/A
LGVN - KZIA
32%
Poorly correlated
N/A
RVMD - KZIA
29%
Poorly correlated
+1.83%
AVCTF - KZIA
26%
Poorly correlated
N/A
IMAB - KZIA
26%
Poorly correlated
-6.11%
More